LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 139

Search options

  1. Article ; Online: A Conversation with Dr. Ludmila Prokunina-Olsson.

    Prokunina-Olsson, Ludmila

    Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research

    2022  Volume 42, Issue 9, Page(s) 462–466

    Language English
    Publishing date 2022-09-19
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1226675-9
    ISSN 1557-7465 ; 1079-9907
    ISSN (online) 1557-7465
    ISSN 1079-9907
    DOI 10.1089/jir.2022.29043.lup
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Call for Special Issue Papers:

    Prokunina-Olsson, Ludmila

    Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research

    2021  Volume 42, Issue 11, Page(s) 551–552

    MeSH term(s) Interferons ; Antiviral Agents
    Chemical Substances Interferons (9008-11-1) ; Antiviral Agents
    Language English
    Publishing date 2021-05-28
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1226675-9
    ISSN 1557-7465 ; 1079-9907
    ISSN (online) 1557-7465
    ISSN 1079-9907
    DOI 10.1089/jir.2022.29044.cfp
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The Interferon-Lambda Family Celebrates 20 Years of Scientific Discovery.

    Donnelly, Raymond P / Prokunina-Olsson, Ludmila

    Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research

    2023  Volume 43, Issue 9, Page(s) 359–362

    Abstract: ... et al., 2003; Sheppard et al., 2003) and 10 years since the subsequent discovery of IFN-λ4 (Prokunina ... Olsson et al., 2013). The IFN-λ family (type III IFNs) includes 4 members: IFN-λ1, 2, 3, and 4, and all 4 ...

    Abstract It has now been 20 years since the original discovery of the interferon λ (IFN-λ) family (Kotenko et al., 2003; Sheppard et al., 2003) and 10 years since the subsequent discovery of IFN-λ4 (Prokunina-Olsson et al., 2013). The IFN-λ family (type III IFNs) includes 4 members: IFN-λ1, 2, 3, and 4, and all 4 of these proteins signal through the same heterodimeric receptor complex: IFN-λR1 plus IL-10R2. Throughout the past 20 years, much has been learned about the IFN-λ family and the important role of these cytokines in antiviral responses against viruses such as hepatitis C virus, influenza A virus, and SARS-CoV-2. This special issue of the
    MeSH term(s) Humans ; Interferon Lambda ; COVID-19 ; SARS-CoV-2 ; Interferons ; Cytokines
    Chemical Substances Interferon Lambda ; Interferons (9008-11-1) ; Cytokines
    Language English
    Publishing date 2023-09-19
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1226675-9
    ISSN 1557-7465 ; 1079-9907
    ISSN (online) 1557-7465
    ISSN 1079-9907
    DOI 10.1089/jir.2023.0122
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Genetics of the Human Interferon Lambda Region.

    Prokunina-Olsson, Ludmila

    Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research

    2019  Volume 39, Issue 10, Page(s) 599–608

    Abstract: Humans are polymorphic in their ability to produce type-III interferons. Most individuals of African ancestry are genetically capable of generating all 4 type-III interferons (IFN-λ1, 2, 3, and 4), whereas the majority of individuals of European and ... ...

    Abstract Humans are polymorphic in their ability to produce type-III interferons. Most individuals of African ancestry are genetically capable of generating all 4 type-III interferons (IFN-λ1, 2, 3, and 4), whereas the majority of individuals of European and Asian ancestry lack IFN-λ4 and thus can generate only IFN-λ1, 2, and 3. All 4 type-III IFNs are encoded by genes located within a ∼55 kb genomic region on human chromosome 19. Although IFN-λ4 appears to be important in animals, genetic alterations acquired in the Hominidae lineage, and particularly in humans, resulted in the elimination of IFN-λ4 or restriction of its activity, suggesting that IFN-λ4 function might be detrimental to human health. Genetic variants within the
    MeSH term(s) Animals ; Chromosomes, Human, Pair 9/genetics ; Chromosomes, Human, Pair 9/metabolism ; Genetic Loci ; Genetic Variation ; Hepacivirus/metabolism ; Hepatitis C/genetics ; Hepatitis C/metabolism ; Hepatitis C/pathology ; Humans ; Interferons/genetics ; Interferons/metabolism
    Chemical Substances interferon type III ; Interferons (9008-11-1)
    Language English
    Publishing date 2019-05-08
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Intramural ; Review
    ZDB-ID 1226675-9
    ISSN 1557-7465 ; 1079-9907
    ISSN (online) 1557-7465
    ISSN 1079-9907
    DOI 10.1089/jir.2019.0043
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Genetics Helps to Find Synergy for Immune Checkpoint and Targeted Combination Therapies.

    Prokunina-Olsson, Ludmila

    Cancer research

    2019  Volume 79, Issue 21, Page(s) 5476–5478

    Abstract: Checkpoint inhibitors, including anti-PD-L1 therapy, emerged as a treatment option for many cancer types, albeit with limited response rates. Combinations of immune-based and -targeted therapies are needed to achieve synergistic antitumor effects and ... ...

    Abstract Checkpoint inhibitors, including anti-PD-L1 therapy, emerged as a treatment option for many cancer types, albeit with limited response rates. Combinations of immune-based and -targeted therapies are needed to achieve synergistic antitumor effects and provide much needed treatment personalization and improved response. Genetic alterations can be used as molecular drug targets and as biomarkers to select patients for specific therapies and their combinations. Fukumoto and colleagues present a promising example of this approach for the treatment of ovarian cancer with inactivating ARID1A mutations using a combination of the checkpoint and histone deacetylase inhibitors.
    MeSH term(s) Combined Modality Therapy ; DNA-Binding Proteins ; Female ; Histone Deacetylase 6 ; Humans ; Immunotherapy ; Molecular Targeted Therapy ; Nuclear Proteins ; Ovarian Neoplasms ; Programmed Cell Death 1 Receptor ; Transcription Factors
    Chemical Substances ARID1A protein, human ; DNA-Binding Proteins ; Nuclear Proteins ; Programmed Cell Death 1 Receptor ; Transcription Factors ; HDAC6 protein, human (EC 3.5.1.98) ; Histone Deacetylase 6 (EC 3.5.1.98)
    Language English
    Publishing date 2019-10-29
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Intramural ; Comment
    ZDB-ID 1432-1
    ISSN 1538-7445 ; 0008-5472
    ISSN (online) 1538-7445
    ISSN 0008-5472
    DOI 10.1158/0008-5472.CAN-19-2528
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: When the Smoke Clears m

    Banday, A Rouf / Papenberg, Brenen W / Prokunina-Olsson, Ludmila

    Cancer research

    2020  Volume 80, Issue 13, Page(s) 2718–2719

    Abstract: Long noncoding RNAs (lncRNA) have been implicated in many diseases, including cancer. Although these disease-associated effects have been mostly attributed to the ability of lncRNAs to function as regulatory noncoding transcripts, there is growing ... ...

    Abstract Long noncoding RNAs (lncRNA) have been implicated in many diseases, including cancer. Although these disease-associated effects have been mostly attributed to the ability of lncRNAs to function as regulatory noncoding transcripts, there is growing evidence that lncRNAs may also encode functional micropeptides. In the current issue of
    MeSH term(s) Cigarette Smoking ; Esophageal Neoplasms ; Esophageal Squamous Cell Carcinoma ; Humans ; Male ; RNA, Long Noncoding/genetics ; Smoke ; Y Chromosome
    Chemical Substances RNA, Long Noncoding ; Smoke
    Language English
    Publishing date 2020-07-02
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Intramural ; Comment
    ZDB-ID 1432-1
    ISSN 1538-7445 ; 0008-5472
    ISSN (online) 1538-7445
    ISSN 0008-5472
    DOI 10.1158/0008-5472.CAN-20-0961
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: It Takes Two (Genomes) to Cancer: Paired Viral and Host Transcriptome Analysis Provides New Insights about EBV Carcinogenicity.

    Mbulaiteye, Sam M / Prokunina-Olsson, Ludmila

    Cancer research

    2019  Volume 79, Issue 23, Page(s) 5917–5919

    Abstract: The discovery of Epstein-Barr virus (EBV) in 1964 gave birth to the field of viral oncology. Despite significant scientific and clinical developments in research on several other viruses discovered and linked to cancer risk much later, our understanding ... ...

    Abstract The discovery of Epstein-Barr virus (EBV) in 1964 gave birth to the field of viral oncology. Despite significant scientific and clinical developments in research on several other viruses discovered and linked to cancer risk much later, our understanding of EBV as a carcinogen and a possible target for therapeutic interventions remains limited. In this issue of
    MeSH term(s) Epstein-Barr Virus Infections/genetics ; Gene Expression Profiling ; Genome, Viral ; Herpesvirus 4, Human ; Humans ; Neoplasms
    Language English
    Publishing date 2019-11-27
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Intramural ; Comment
    ZDB-ID 1432-1
    ISSN 1538-7445 ; 0008-5472
    ISSN (online) 1538-7445
    ISSN 0008-5472
    DOI 10.1158/0008-5472.CAN-19-2996
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: The IFN-λ4 Conundrum: When a Good Interferon Goes Bad.

    Onabajo, Olusegun O / Muchmore, Brian / Prokunina-Olsson, Ludmila

    Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research

    2019  Volume 39, Issue 10, Page(s) 636–641

    Abstract: Since its discovery in 2013, interferon lambda 4 (IFN-λ4) has received a reputation as a paradoxical type III IFN. Difficulties in detecting IFN-λ4, especially in secreted form even led to questions about its existence. However, the genetic ability to ... ...

    Abstract Since its discovery in 2013, interferon lambda 4 (IFN-λ4) has received a reputation as a paradoxical type III IFN. Difficulties in detecting IFN-λ4, especially in secreted form even led to questions about its existence. However, the genetic ability to generate IFN-λ4, determined by the presence of the rs368234815-ΔG allele, is the strongest predictor of impaired clearance of hepatitis C virus (HCV) infection in humans. Significant modulation of IFN-λ4 activity by a genetic variant (P70S) supports IFN-λ4, and not other type III IFNs encoded in the same genomic locus, as the primary functional cause of the association with HCV clearance. Although the ability to produce IFN-λ4 is associated with decreased HCV clearance, the recombinant IFN-λ4 is active against HCV and other viruses. These observations present an apparent conundrum-when and how does a presumably good IFN, with anti-HCV activity, interfere with the ability to clear HCV? In this review, we discuss findings that suggest potential mechanisms for explaining this conundrum.
    MeSH term(s) Hepacivirus/genetics ; Hepacivirus/metabolism ; Hepatitis C/genetics ; Hepatitis C/metabolism ; Hepatitis C/pathology ; Humans ; Interleukins/genetics ; Interleukins/metabolism ; Polymorphism, Genetic
    Chemical Substances IFNL4 protein, human ; Interleukins
    Language English
    Publishing date 2019-06-26
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Intramural ; Review
    ZDB-ID 1226675-9
    ISSN 1557-7465 ; 1079-9907
    ISSN (online) 1557-7465
    ISSN 1079-9907
    DOI 10.1089/jir.2019.0044
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: What makes the hepatitis C virus evolve?

    O'Brien, Thomas R / Hartmann, Rune / Prokunina-Olsson, Ludmila

    eLife

    2019  Volume 8

    Abstract: Polymorphisms in ... ...

    Abstract Polymorphisms in the
    MeSH term(s) Antiviral Agents ; Genotype ; Hepacivirus ; Interferons ; Interleukins
    Chemical Substances Antiviral Agents ; Interleukins ; Interferons (9008-11-1)
    Language English
    Publishing date 2019-09-03
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Intramural ; Comment
    ZDB-ID 2687154-3
    ISSN 2050-084X ; 2050-084X
    ISSN (online) 2050-084X
    ISSN 2050-084X
    DOI 10.7554/eLife.50148
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Nitrated Polycyclic Aromatic Hydrocarbon (Nitro-PAH) Signatures and Somatic Mutations in Diesel Exhaust-Exposed Bladder Tumors.

    Gonzalez, Nicole / Rao, Nina / Dean, Michael / Lee, Donghyuk / Hurson, Amber N / Baris, Dalsu / Schwenn, Molly / Johnson, Alison / Prokunina-Olsson, Ludmila / Friesen, Melissa C / Zhu, Bin / Rothman, Nathaniel / Silverman, Debra T / Koutros, Stella

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

    2023  Volume 32, Issue 6, Page(s) 840–847

    Abstract: Background: Diesel exhaust is a complex mixture, including polycyclic aromatic hydrocarbons (PAH) and nitrated PAHs (nitro-PAH), many of which are potent mutagens and possible bladder carcinogens. To explore the association between diesel exposure and ... ...

    Abstract Background: Diesel exhaust is a complex mixture, including polycyclic aromatic hydrocarbons (PAH) and nitrated PAHs (nitro-PAH), many of which are potent mutagens and possible bladder carcinogens. To explore the association between diesel exposure and bladder carcinogenesis, we examined the relationship between exposure and somatic mutations and mutational signatures in bladder tumors.
    Methods: Targeted sequencing was conducted in bladder tumors from the New England Bladder Cancer Study. Using data on 797 cases and 1,418 controls, two-stage polytomous logistic regression was used to evaluate etiologic heterogeneity between bladder cancer subtypes and quantitative, lifetime estimates of respirable elemental carbon (REC), a surrogate for diesel exposure. Poisson regression was used to evaluate associations between REC and mutational signatures.
    Results: We observed significant heterogeneity in the diesel-bladder cancer risk relationship, with a strong positive association among cases with high-grade, nonmuscle invasive TP53-mutated tumors compared with controls [ORTop Tertile vs.Unexposed, 4.8; 95% confidence interval (CI), 2.2-10.5; Ptrend < 0.001; Pheterogeneity = 0.002]. In muscle-invasive tumors, we observed a positive association between diesel exposure and the nitro-PAH signatures of 1,6-dintropyrene (RR, 1.93; 95% CI, 1.28-2.92) and 3-nitrobenzoic acid (RR, 1.97; 95% CI, 1.33-2.92).
    Conclusions: The relationship between diesel exhaust and bladder cancer was heterogeneous based on the presence of TP53 mutations in tumors, further supporting the link between PAH exposure and TP53 mutations in carcinogenesis. Future studies that can identify nitro-PAH signatures in exposed tumors are warranted to add human data supporting the link between diesel and bladder cancer.
    Impact: This study provides additional insight into the etiology and possible mechanisms related to diesel exhaust-induced bladder cancer.
    MeSH term(s) Humans ; Vehicle Emissions/toxicity ; Polycyclic Aromatic Hydrocarbons/toxicity ; Nitrates ; Urinary Bladder Neoplasms/chemically induced ; Urinary Bladder Neoplasms/epidemiology ; Urinary Bladder Neoplasms/genetics ; Mutation ; Carcinogenesis
    Chemical Substances Vehicle Emissions ; Polycyclic Aromatic Hydrocarbons ; Nitrates
    Language English
    Publishing date 2023-04-01
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Intramural
    ZDB-ID 1153420-5
    ISSN 1538-7755 ; 1055-9965
    ISSN (online) 1538-7755
    ISSN 1055-9965
    DOI 10.1158/1055-9965.EPI-22-1208
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top